No rules without exception: a long-term complete remission observed in a study using a LH-RH agonist in platinum-refractory ovarian cancer.
Paskeviciute
L
L
Department of Oncology, The Finsen Center, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark. ligitapask@dadlnet.dk
Roed
H
H
Engelholm
A
A
D000328:Adult; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017671:Platinum Compounds / Q000627:therapeutic use; D012074:Remission Induction
D018931:Antineoplastic Agents, Hormonal; D017671:Platinum Compounds; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide